Trials / Completed
CompletedNCT00225862
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
A 12-week, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Intermittent Dosing of Ropinirole in Patients With Restless Legs Syndrome (RLS)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A 12-week clinical research study to evaluate the tolerability, efficacy and safety of ropinirole compared to placebo(an inactive sugar pill) in the treatment of patients with RLS in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ropinirole |
Timeline
- Start date
- 2005-01-01
- Completion
- 2005-12-01
- First posted
- 2005-09-26
- Last updated
- 2016-09-15
Locations
37 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00225862. Inclusion in this directory is not an endorsement.